Firstline

🔬 A new study on early antibiotic switch!

The ESCMID - Clinical Microbiology and Infection Journal recently published a compelling study by Cornelia B. Landersdorfer, Amanda Gwee, and Roger L. Nation emphasizing the substantial benefits of transitioning from intravenous (IV) to oral antibiotics earlier in treatment.

Key benefits include:
1️⃣ Shorter hospital stays
2️⃣ Decreased healthcare costs
3️⃣ Fewer IV-related complications

The research challenges the perceived barriers to an early IV to oral antibiotic switch, revealing that many of these barriers may not be as significant as previously believed.

📚 Let's embrace these findings and explore adopting early antibiotic switches in appropriate cases:
https://buff.ly/3ohB6k9

Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived? Traditionally, there has been a common belief that ongoing intravenous (IV) antibiotic therapy is superior to an early IV to oral switch, especially for severe infections. However, this may be at least partly based on early observations rather than robust, high quality data and contemporary clinical...